Impact of ileal pouch-anal anastomosis on the surgical outcome of orthotopic liver transplantation for primary sclerosing cholangitis

Journal of Crohn's and Colitis

Volumn 7, Issue 3, 2013, Pages 230-238

  Obusez, Emmanuel C ^a   Lian, Lei ^b   Shao, Zhuo ^c   Navaneethan, Udayakumar ^a   O'Shea, Robert ^a   Kiran, Ravi P ^a   Shen, Bo ^a  

^a CLEVELAND CLINIC LERNER COLLEGE OF MEDICINE   (United States)

^b THE SIXTH AFFILIATED HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

^c SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Ileal pouch anal anastomosis; Inflammatory bowel disease; Orthotopic liver transplantation; Primary sclerosing cholangitis; Restorative proctocolectomy; Ulcerative colitis

Indexed keywords

ANTIBIOTIC AGENT; CORTICOSTEROID; COTRIMOXAZOLE; CYCLOSPORIN; GANCICLOVIR; METRONIDAZOLE; MYCOPHENOLIC ACID; PREDNISONE; RAPAMYCIN; SALAZOSULFAPYRIDINE; SUCRALFATE; TACROLIMUS; URSODEOXYCHOLIC ACID; VALGANCICLOVIR;

ABDOMINAL ABSCESS; ACUTE GRAFT REJECTION; ACUTE KIDNEY FAILURE; ADULT; ANASTOMOSIS; ANTIBIOTIC PROPHYLAXIS; ARTICLE; ASCITES LEAK; BACTEREMIA; BACTERIAL INFECTION; BILE LEAKAGE; CHOLESTASIS; CHRONIC GRAFT REJECTION; CHRONIC KIDNEY FAILURE; DRUG MANUFACTURE; FEMALE; FOLLOW UP; GRAFT REJECTION; GRAFT SURVIVAL; HEPATIC THROMBOSIS; HUMAN; ILEAL POUCH ANAL ANASTOMOSIS; LIVER TRANSPLANTATION; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PNEUMOCYSTOSIS; POSTOPERATIVE COMPLICATION; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL; ULCERATIVE COLITIS;

ADULT; CHOLANGITIS, SCLEROSING; COHORT STUDIES; COLITIS, ULCERATIVE; FEMALE; GRAFT SURVIVAL; HUMANS; KAPLAN-MEIER ESTIMATE; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; POSTOPERATIVE COMPLICATIONS; PROCTOCOLECTOMY, RESTORATIVE; RETROSPECTIVE STUDIES; RISK FACTORS; TREATMENT OUTCOME;

EID: 84873737875     PISSN: 18739946     EISSN: 18764479     Source Type: Journal    
DOI: 10.1016/j.crohns.2012.06.001     Document Type: Article

References (32)

1. Wiesner R.H., Grambsch P.M., Dickson E.R., Ludwig J., MacCarty R.L., Hunter E.B., et al. Primary sclerosing cholangitis: natural history, prognostic factors and survival analysis. Hepatology 1989, 10(4):430-436.
2. Langnas A.N., Grazi G.L., Stratta R.J., Wood R.P., Marujo W., Markin R.S., et al. Primary sclerosing cholangitis: the emerging role for liver transplantation. Am J Gastroenterol 1990, 85(9):1136-1141.
3. Navaneethan U., Shen B. Hepatopancreatobiliary manifestations and complications associated with inflammatory bowel disease. Inflamm Bowel Dis 2010, 16(9):1598-1619.
4. Bambha K., Kim W.R., Talwalkar J., Torgerson H., Benson J.T., Therneau T.M., et al. Incidence, clinical spectrum, and outcomes of primary sclerosing cholangitis in a United States community. Gastroenterology 2003, 125(5):1364-1369.
5. Eade M.N. Liver disease in ulcerative colitis. I. Analysis of operative liver biopsy in 138 consecutive patients having colectomy. Ann Intern Med 1970, 72(4):475-487.
6. Fazio V.W., Ziv Y., Church J.M., Oakley J.R., Lavery I.C., Milsom J.W., et al. Ileal pouch-anal anastomoses complications and function in 1005 patients. Ann Surg Aug 1995, 222(2):120-127.
7. Freeman K., Shao Z., Remzi F.H., Lopez R., Fazio V.W., Shen B. Impact of orthotopic liver transplant for primary sclerosing cholangitis on chronic antibiotic refractory pouchitis. Clin Gastroenterol Hepatol Jan 2008, 6(1):62-68.
8. Cho C.S., Dayton M.T., Thompson J.S., Koltun W.A., Heise C.P., Harms B.A. Proctocolectomy-ileal pouch-anal anastomosis for ulcerative colitis after liver transplantation for primary sclerosing cholangitis: a multi-institutional analysis. J Gastrointest Surg 2008, 12(7):1221-1226.
9. Wiesner R.H. Liver transplantation for primary sclerosing cholangitis: timing, outcome, impact of inflammatory bowel disease and recurrence of disease. Best Pract Res Clin Gastroenterol 2001, 15(4):667-680.
10. Marsh J.W., Iwatsuki S., Makowka L., Esquivel C.O., Gordon R.D., Todo S., et al. Orthotopic liver transplantation for primary sclerosing cholangitis. Ann Surg 1988, 207(1):21-25.
11. Garner J.S., Jarvis W.R., Emori T.G., Horan T.C., Hughes J.M. CDC definitions of nosocomial infections. Am J Infect Control 1988, 16:128-140.
12. Goss J.A., Shackleton C.R., Farmer D.G., Arnaout W.S., Seu P., Markowitz J.S., et al. Orthotopic liver transplantation for primary sclerosing cholangitis. A 12-year single center experience. Ann Surg 1997, 225(5):472-481.
13. Mathis K.L., Dozois E.J., Larson D.W., Cima R.R., Sarmiento, Wolff B.G., et al. Ileal pouch-anal anastomosis and liver transplantation for ulcerative colitis complicated by primary sclerosing cholangitis. Br J Surg 2008, 95(7):882-886.
14. Graziadei I.W., Wiesner R.H., Marotta P.J., Porayko M.K., Hay J.E., Charlton M.R., et al. Long-term results of patients undergoing liver transplantation for primary sclerosing cholangitis. Hepatology 1999, 30(5):1121-1127.
15. Shaked A., Colonna J.O., Goldstein L., Busuttil R.W. The interrelation between sclerosing cholangitis and ulcerative colitis in patients undergoing liver transplantation. Ann Surg 1992, 215(6):598-603.
16. Narumi S., Roberts J.P., Edmond J.C., Lake J., Ascher N.L. Liver transplantation for sclerosing cholangitis. Hepatology 1995, 22(2):451-457.
17. Kusne S., Dummer J.S., Singh N., Iwatsuki S., Makowka L., Esquivel C., et al. Infections after liver transplantation. An analysis of 101 consecutive cases. Medicine (Baltimore) 1988, 67(2):132-143.
18. Kim Y.J., Kim S.I., Wie S.H., Kim Y.R., Hur J.A., Choi J.Y., et al. Infectious complications in living-donor liver transplant recipients: a 9-year single-center experience. Transpl Infect Dis 2008, 10(5):316-324.
19. Mark W., Graziadei I., Bargehr D., Vogel W., Boesmueller C., Tabarelli W., et al. Infectious complications limit the outcome of liver transplantation in medical urgency code 2 patients. Transplant Proc 2005, 37(2):1224-1226.
20. Patel R., Paya C.V. Infections in solid-organ transplant recipients. Clin Microbiol Rev 1997, 10(1):86-124.
21. Snydman D.R. Infection in solid organ transplantation. Transpl Infect Dis 1999, 1(1):21-28.
22. Winston D.J., Emmanouilides C., Busuttil R.W. Infections in liver transplant recipients. Clin Infect Dis 1995, 21(5):1077-1089.
23. Singh N., Gayowski T., Wagener M., Yu V.L. Infectious complications in liver transplant recipients on tacrolimus. Prospective analysis of 88 consecutive liver transplants. Transplantation 1994, 58(7):774-778.
24. George D.L., Arnow P.M., Fox A.S., Baker A.L., Thistlethwaite J.R., Emond J.C., et al. Bacterial infection as a complication of liver transplantation: epidemiology and risk factors. Rev Infect Dis 1991, 13(3):387-396.
25. Fishman J.A. Infection in solid-organ transplant recipients. N Engl J Med 2007, 357(25):2601-2614.
26. Singh N. Impact of current transplantation practices on the changing epidemiology of infections in transplant recipients. Lancet Infect Dis 2003, 3(3):156-161.
27. Villacian J.S., Paya C.V. Prevention of infections in solid organ transplant recipients. Transpl Infect Dis 1999, 1(1):50-64.
28. Paya C.V., Hermans P.E., Washington J.A., Smith T.F., Anhalt J.P., Wiesner R.H., et al. Incidence, distribution, and outcome of episodes of infection in 100 orthotopic liver transplantations. Mayo Clin Proc 1989, 64(5):555-564.
29. Colonna J.O., Winston D.J., Brill J.E., Goldstein L.I., Hoff M.P., Hiatt J.R., et al. Infectious complications in liver transplantation. Arch Surg 1988, 123(3):360-364.
30. Wade J.J., Rolando N., Hayllar K., Philpott-Howard J., Casewell M.W., Williams R. Bacterial and fungal infections after liver transplantation: an analysis of 284 patients. Hepatology 1995, 21(5):1328-1336.
31. Kim S.I., Kim Y.J., Jun Y.H., Wie S.H., Kim Y.R., Choi J.Y., et al. Epidemiology and risk factors for bacteremia in 144 consecutive living-donor liver transplant recipients. Yonsei Med J 2009, 50(1):112-121.
32. Reid G.E., Grim S.A., Sankary H., Benedetti E., Oberholzer J., Clark N.M. Early intra-abdominal infections associated with orthotopic liver transplantation. Transplantation 2009, 87(11):1706-1711.